Vidya H Veldore
Overview
Explore the profile of Vidya H Veldore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ranganathan K, Kurian N, Goswami H, Rishi K, Veldore V
J Liq Biopsy
. 2025 Mar;
5:100150.
PMID: 40027943
Various tumor cells may exhibit different genetic or phenotypic characteristics. This phenomenon of cancer cells, known as Tumor Heterogeneity, is responsible for multiple cancer sites caused in a single patient...
2.
Prabhash K, Saldanha E, Patil V, Bal M, Reddy P S, Sanjeev A, et al.
JCO Precis Oncol
. 2024 May;
8:e2300622.
PMID: 38754058
Purpose: Medullary thyroid cancer (MTC) is a rare cancer originating from parafollicular C cells of the thyroid gland. Therapeutically relevant alterations in MTC are predominantly reported in oncogene, and lower-frequency...
3.
Malhotra R, Javle V, Tanwar N, Gowda P, Varghese L, K A, et al.
Front Oncol
. 2023 Mar;
13:1002792.
PMID: 36994199
Introduction: The concept of personalized medicine in cancer has emerged rapidly with the advancement of genome sequencing and the identification of clinically relevant variants that contribute to disease prognosis and...
4.
Veldore V, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, et al.
Lung Cancer (Auckl)
. 2018 Jan;
9:1-11.
PMID: 29379323
Plasma cell-free tumor DNA, or circulating tumor DNA (ctDNA), from liquid biopsy is a potential source of tumor genetic material, in the absence of tissue biopsy, for testing. Our validation...
5.
Veldore V, Patil S, Satheesh C, Shashidhara H, Tejaswi R, Prabhudesai S, et al.
Indian J Cancer
. 2016 Feb;
52(2):243-8.
PMID: 26853422
Background: Patients' who are positive for kinase domain activating mutations in epidermal growth factor receptor (EGFR) gene, constitute 30-40% of non-small cell lung cancer (NSCLC), and are suitable candidates for...
6.
Veldore V, Patil S, Prabhudesai S, Satheesh C, Shashidhara H, Krishnamoorthy N, et al.
Mol Diagn Ther
. 2016 Jan;
20(2):119-23.
PMID: 26740090
Background: Although biopsy is the gold standard for diagnosis, cytological material has often been used to assist in making a pathologic diagnosis as well as for molecular testing in certain...
7.
Venkataswamy E, Nargund A, Prabhudesai S, Patil G, Chandra R, Veldore V, et al.
Indian J Hum Genet
. 2013 May;
18(3):349-51.
PMID: 23716946
Del(5)(q) is a common chromosomal abnormality with favourable prognosis in Myelodysplastic Syndrome (MDS) and Acute myeloid leukemia (AML). However, del(5)(q) is also seen rarely in Acute lymphoblastic leukemia (ALL) and...